首页 >
法规速递
-
CVM GFI #91 (VICH GL8 (R)) Stability Testing for Medicated Premix (or Type A Medicated Article) (Revision 1)-2026/4/21
2026-04-22查看详情 > -
Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA(Draft)-2023/02/17
2023-02-17查看详情 > -
国家药监局关于适用《S12：基因治疗产品非临床生物分布的考虑》国际人用药品注册技术协调会 指导原则的公告（2023年第115号）-2023/9/5
2023-09-06查看详情 > -
Validation and Verification of Analytical Testing Methods Used for Tobacco Products-2025/1/6
2025-01-07查看详情 > -
Page: EudraVigilance training and support-2025/2/6
2025-02-10查看详情 > -
Page: Frequently asked questions-2025/3/14
2025-03-17查看详情 > -
Page: Fees payable to the European Medicines Agency-2025/4/15
2025-04-16查看详情 > -
《麻醉药品和精神药品实验研究管理规定》政策解读 -2025/5/30
2025-05-30查看详情 > -
Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment-2025/7/2
2025-07-03查看详情 > -
Document: Concept paper on the need for revision of the guideline on the clinical investigation of medicines for the treatment of Alzheimer's disease-2025/8/6
2025-08-06查看详情 >
